echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Indomethacin, meloxicam, celecoxib... What should I pay attention to when choosing non-steroidal anti-inflammatory drugs for the treatment of rigidity?

    Indomethacin, meloxicam, celecoxib... What should I pay attention to when choosing non-steroidal anti-inflammatory drugs for the treatment of rigidity?

    • Last Update: 2022-05-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The "inflammation" in ankylosing spondylitis is part of the body's innate immune system (the first line of defense against disease and injury), but if the inflammatory response persists for too long, it can lead to a condition called chronic inflammation.


    Immunization What are NSAIDs?

    Steroids generally refer to steroids (hormones as we understand them), while nonsteroidal anti-inflammatory drugs (NSAIDs) refer to non-hormonal anti-inflammatory drugs


    Aspirin, indomethacin, naproxen, ibuprofen, diclofenac, loxoprofen, meloxicam, celecoxib, etoricoxib, and parecoxib are all non-steroidal body anti-inflammatory drugs


    Aspirin, indomethacin, naproxen, ibuprofen, diclofenac, loxoprofen, meloxicam, celecoxib, etoricoxib, parecoxib

    What is the role of NSAIDs in ankylosing spondylitis?

    The common inflammatory mediators in patients with ankylosing spondylitis include prostaglandins, interleukins and tumor necrosis factor , etc.


    Prostaglandins, interleukins and tumor necrosis factor It acts on cyclooxygenase and inhibits the synthesis of prostaglandins from arachidonic acid, thereby inhibiting inflammation and reducing pain


    It should be noted, however, that ankylosing spondylitis also has a distinctive feature - new bone formation


    But it should be noted that new bone formation quality of life

    Due to the limited effect of non-steroidal anti-inflammatory drugs on the control of deep inflammation in the joint cavity, it is "powerless" for local soft tissue adhesion, so it is difficult to prevent the formation of osteophytes.


    Due to the limited effect of non-steroidal anti-inflammatory drugs on the control of deep inflammation in the joint cavity, it is "powerless" for local soft tissue adhesion, so it is difficult to prevent the formation of osteophytes.


    01 Gastrointestinal tract

    01 Gastrointestinal tract

    Abdominal discomfort, dull pain, nausea, vomiting, fullness, belching, loss of appetite and other indigestion symptoms may occur


    Digestion Digestion

    02 Liver

    02 Liver

    At therapeutic doses, 10% of patients developed biochemical abnormalities with mild liver damage, but significantly elevated alanine aminotransferase levels occurred in less than 2%


    03 Nervous system

    03 Nervous system

    Headache, dizziness, tinnitus, deafness, amblyopia, drowsiness, insomnia, paresthesia, numbness, etc.


    04Urinary system

    04Urinary system

    It can cause proteinuria, cast urine, red and white blood cells, etc.


    05Blood system

    05Blood system

    Some NSAIDs can cause neutropenia, aplastic anemia, and coagulation disorders


    06 Allergies

    06 Allergies

    Idiopathic people may have allergic reactions such as rash, angioedema , and asthma


    Blood vessel

    07 Cardiovascular System

    07 Cardiovascular System

    Studies have found that NSAIDs can significantly interfere with blood pressure and increase mean arterial pressure


    cardiovascular events

    08 Pregnancy

    08 Pregnancy

    Non-steroidal anti-inflammatory drugs are considered to be a potential factor in the induction of acute fatty liver of pregnancy; aspirin in pregnant women can cause bleeding during prenatal, postpartum, and delivery; indomethacin may cause some fetal brachymorphs, penile hypoplasia


    How to reduce the incidence of side effects?

    ① In clinical application, the combined use of two or more NSAIDs should be avoided
    .

    ② For patients with gastrointestinal discomfort or peptic ulcer, COX-2 inhibitors are preferred instead of traditional non-steroidal anti-inflammatory drugs, and gastric drugs should be added if necessary
    .

    ③ For patients with only high cardiovascular risk and no other risk factors, consider the priority use of naproxen
    .

    ④ While using non-steroidal anti-inflammatory drugs, if the situation allows, avoid the use of diuretics, ACEI/ARB antihypertensive drugs and other drugs that may affect renal perfusion at the same time
    .

    ⑤ NSAIDs have a capping effect, and overdose should be avoided
    .
    Overdose, the efficacy does not increase, but the side effects will increase significantly
    .

    ⑥ Necessary blood and renal function monitoring should be carried out regularly under the guidance of a doctor
    .



    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.